A Johnson & Johnson unit holding talc-related asbestos liabilities moved to file an updated lawsuit accusing a medical expert ...

The International Agency for Research on Cancer (IARC) has published a new assessment of talc’s potential to cause cancer, concluding that is it ‘probably carcinogenic’ to humans.

The stable outlook reflects S&P Global Ratings’ belief that Johnson & Johnson will continue to generate steady growth from its pharmaceutical and med tech franchises and generally maintain adjusted ...

The jury in a New Jersey trial has awarded $750 million in punitive damages against Johnson & Johnson in a case brought by four people who claimed they had developed cancer after using its talc ...

Invitations for screening appointments are usually issued every three years to individuals aged between 50 and 71 ...

Anyone over the age of 53 who believes they are due an appointment should get in touch with their local screening office ...

Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...

Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to ...

Despite some optimism in the market after President Donald Trump’s indication of possible talks with China, Wall Street ...

Adam Parker, Trivariate Research CEO, said in a recent interview with CNBC that it’s “hard” to be bullish in this market ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

Anyone over the age of 53 who believes they are due an appointment should get in touch with their local screening office ...